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Introduction
Ficus racemosa Linn. (Moraceae), commonly known 
as “gular”, is widely distributed all over India and other 
parts of Asia (CSIR, 1952; Kulkarni & Ansari, 2004). All 
parts of this plant are medicinally important in the tra-
ditional system of medicine in India and have been used 
extensively in biliary disorders, jaundice, dysentery, 
diabetes, diarrhea, and as an anti-inflammatory agent 
(Kirtikar & Basu, 1975; Nadkarni et al., 1976; Chopra 
et al., 1958). The stem bark of F. racemosa is used in 
folklore medicine for treatment of coughs and colds 
(Chopra et al., 1958). An infusion of bark is employed 
as a mouth wash for spongy gum condition and the 
decoction is used in treating various skin diseases and 
ulcers. It is used as a poultice in inflammatory swelling 
and boils. It is reported to be effective in the treatment 
of hemorrhoids, dysentery, asthma, gonorrhea, gleet, 
menorrhagia, leucorrhea, hemoptysis, and urinary 
diseases (CSIR, 1952; Kirtikar & Basu, 1975; Nadkarni 
et al., 1976). F. racemosa is reported to possess various 
biological effects such as hepatoprotective, chemopre-
ventive, antidiabetic, anti-inflammatory, antipyretic, 
antitussive, antidiarrheal and antidiuretic (Mandal 
et al., 2003; Khan & Sultana, 2005; Rao et al., 2002a, 
2002b, 2003; Mandal et al., 2000; Mukherjee et al., 1998; 
Ratnasooriya et al., 2003).
Carbon tetrachloride (CCl
4
), an industrial solvent, 
is a well-established hepatotoxin. Various studies have 
demonstrated that the liver is not the only target organ 
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Abstract
In the present study, the hepatoprotective effects of petroleum ether (FRPE) and methanol (FRME) extract 
of Ficus racemosa Linn. (Moraceae) stem bark were studied using the model of hepatotoxicity induced by 
carbon tetrachloride (CCl4) in rats. CCl4 administration induced a significant decrease in serum total protein, 
albumin, urea and a significant increase (P ≤ 0.01) in total bilirubin associated with a marked elevation in 
the activities of aspartate aminotransferase (AST), alanine aminotransferase (ALT) and alkaline phosphatase 
(ALP) as compared to control rats. Further, CCl4 intoxication caused significant increase in the TBARS and 
decrease in glutathione (GSH) levels in serum, liver and kidney. Pretreatment with FRPE and FRME restored 
total protein and albumin to near normal levels. Both the extracts resulted in significant decreases in the 
activities of AST, ALT and ALP, compared to CCl4-treated rats. However, a greater degree of reduction was 
observed in FRME pretreated group (FRPE 43%, 38%, and 33%; FRME 55%, 73%, and 38%). Total bilirubin 
content decreased from 2.1 mg/dL in CCl4-treated rats to 0.8 and 0.3 mg/dL in FRPE and FRME pretreated 
rats, respectively. The extracts improved the antioxidant status considerably as reflected by low TBARS and 
high GSH values. FRME exhibited higher hepatoprotective activity than a standard liver tonic (Liv52), while 
the protective effect of FRPE was similar to that of Liv52. The protective effect of F. racemosa was confirmed 
by histopathological profiles of the liver. The results indicate that F. racemosa possesses potent hepatopro-
tective effects against CCl4-induced hepatic damage in rats.
Keywords:  Ficus racemosa; hepatoprotective; CCl4; oxidative stress; liver damage; hepatic enzymes
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of CCl
4
 and it causes free radical generation in other tis-
sues also such as kidneys, heart, lung, testis, brain and 
blood (Ahmad et al., 1987; Ohta et al., 1997; Ozturk et al., 
2003). It has also been reported that exposure to CCl
4
 
induces acute and chronic renal injuries (Perez et al., 
1987; Churchill et al., 1983). In view of this, the present 
study evaluated the protective effects of F. racemosa 
bark on liver damage caused by CCl
4
 in Wistar rats and 
observed the changes in the antioxidant defenses.
Materials and methods
Chemicals and reagents
Total protein, albumin assay kits (Span Diagnostics, Surat, 
India), alanine aminotransferase (ALT), aspartate ami-
notransferase (AST), alkaline phosphatase (ALP), total 
bilirubin, urea, creatinine (Agappe Diagnostics, Ernakulam, 
India) assay kits and Liv52 (Himalaya Healthcare, 
Bangalore, India), a standard liver tonic, were used. 5,5-
dithio (bis) nitro benzoic acid (DTNB) was purchased from 
Sigma Aldrich (Bangalore, India). All the chemicals and 
reagents used in the study were of analytical grade.
Collection of plant material
Ficus racemosa stem bark was collected from 
Mukkadahally, Chamarajanagar district of Karnataka, 
India, during September 2007, subsequently identi-
fied by Shivprasad Hudeda, and the voucher specimen 
(BOT-001/2008) was deposited at the herbarium of the 
Department of Studies in Botany, University of Mysore. 
The bark was cut into small pieces, dried (50°C) and pow-
dered, passed through 60 mesh sieve (BS) and stored in 
an airtight container at 4°C until further use.
Preparation of the extracts
The bark powder was extracted sequentially with petro-
leum ether and methanol. Evaporation of respective 
solvents in a rotary vacuum evaporator yielded petro-
leum ether extract - a sticky yellow mass (2.5% w/w), 
and methanol extract - a reddish brown solid mass 
(5.3% w/w). The extracts were homogenized with olive 
oil (1:5 w/v) and the rats were force fed using a feeding 
tube.
Animals
Healthy male Wistar rats between 8 and 9 weeks of age 
and weighing 140-160 g were obtained from the central 
animal house, Dept of Zoology, University of Mysore, 
and divided into 5 groups (n = 6): Control group, nor-
mal rats; FRPE group, petroleum ether extract-treated 
rats (500 mg/kg bw); FRME group, methanol extract-
treated rats (500 mg/kg bw); LIV group, Liv52-treated 
rats (2.5 mL/kg bw); CCl
4
 group, untreated rats. All the 
groups other, than FRPE and FRME, received olive oil 
(1 mL/kg bw) in order to maintain uniformity. The rats 
were housed in polyacrylic cages and maintained at 
27° ± 2°C, 45-60% relative humidity and 12 h photo 
period. The rats were provided with a standard pellet 
diet (Amrut Feeds, Pune, India) and water ad libitum. 
All animal procedures have been approved by the 
Animal Ethical Committee of the University of Mysore 
in accordance with animal experimentation and care.
Experimental design
Rats were treated with FRPE and FRME 
500 mg/kg orally once a day for 7 days, and then a 
mixture 0.5 mL/kg (i.p.) of CCl
4
 in olive oil (1:1) was 
injected twice at 12 and 36 h after the final administra-
tion of FRPE and FRME. The animals were starved over-
night before sacrifice in order to minimize  variations 
in hepatic metabolism. The rats were anesthetized 
and decapitated 12 h after the final administration of 
CCl
4
 (Lim et al., 2000). Blood was collected by direct 
cardiac puncture, and liver and kidneys were imme-
diately excised. Portions of the liver and kidneys were 
homogenized (1:5 w/v) in phosphate-buffered saline 
(pH 7.4) for estimation of TBARS and GSH, while the 
other portion of the greater hepatic lobes were excised 
for histo-pathological studies.
Assays for hepatotoxicity
The activities of alanine aminotransferase, aspartate 
aminotransferase and alkaline phosphatase activities 
were determined in serum according to the procedures 
given in the respective assay kits. The contents of glu-
tathione (GSH) and TBARS in serum, liver and kidneys 
were determined by the methods of Ellman (1959) and 
Ohkawa et al. (1979) respectively. Total bilirubin, total 
protein, albumin, urea and creatinine contents in serum 
were also determined using assay kits.
Histo-pathological procedures
Liver fragments were fixed in a 10% solution of for-
maldehyde and then dehydrated in graduated ethanol 
(50-100%), cleared in xylene and embedded in paraf-
fin. The hepatic sections (4–5 m) were examined with 
a photomicroscope after staining with hematoxylin 
and eosin (H-E) dye. Liver morphological changes 
included cell necrosis, fatty and hydropic degenerative 
changes. The histopathological studies of liver sec-
tions were carried out at Ravi Diagnostic Laboratory, 
Mysore, India.
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Statistical analysis
The values are expressed as mean ± SD. The data was 
analyzed by ANOVA followed by Tukey’s multiple com-
parisons test for significant differences using SPSS 11.0 
software. The values were considered significant at 
p ≤ 0.05.
Results
Effect of FRPE and FRME on serum proteins, urea, 
creatinine and total bilirubin
The data on serum proteins, urea, creatinine and total 
bilirubin levels of various groups is given in Table 1. A 
significant decrease (p ≤ 0.05) in serum total protein 
(hypoproteinemia) was observed in CCl
4
 injected rats. 
However, the total protein concentration was restored 
nearer to control levels in FRME-treated rats. A similar 
trend was observed with respect to serum albumin, 
where a greater decrease in albumin was observed in 
CCl
4
 injected rats and FRME pretreatment restored 
albumin levels nearer to control levels, while FRPE and 
Liv52 restored albumin levels only to a marginal extent.
A significant decrease (p ≤ 0.05) in serum urea con-
centration was observed in CCl
4
-treated rats, while no 
significant differences were observed with respect to the 
serum creatinine levels among various groups. FRPE and 
FRME treatment did not cause any significant change in 
serum urea and creatinine levels as compared to those 
in CCl
4
-treated rats. The total bilirubin content in FRME 
pretreated rats was comparable with that of control rats. 
The bilirubin content in FRPE pretreated rats was com-
parable with that of Liv52 pretreated rats and was signifi-
cantly lower (p ≤ 0.05) then that of CCl
4
-treated rats.
Effect of FRPE and FRME on serum transaminases, 
alkaline phosphatase (ALP)
Pretreatment with FRPE and FRME attenuated the 
increase in the activities of AST, ALT and ALP indicat-
ing their protective effect against CCl
4
-induced hepatic 
damage/injury (Figure 1). FRME exhibited maximum 
inhibition of the activities of AST, ALT and ALP nearer to 
those of control levels. FRPE and Liv52 exhibited similar 
but significant hepatoprotective effect.
Effect of FRPE and FRME on serum, hepatic, renal 
TBARS and GSH
The effect of FRPE, FRME and Liv52 on antioxidant status 
is shown in Figure 2. Pretreatment with FRPE and FRME 
significantly decreased (p ≤ 0.05) the lipid peroxidation 
induced by CCl
4
 as reflected by lower TBARS values in 
serum, liver and kidneys. Liv52 also decreased the oxida-
tive stress significantly (p ≤ 0.05) and it was comparable 
with that of FRPE. However, none of the extracts resulted 
in complete reversal of the oxidative stress to normal 
levels. FRME significantly restored the depleted GSH 
levels similar to that of control rats. FRPE also restored 
the GSH but it did not reach the control levels. The Liv52 
also exhibited GSH restoration effect which was similar 
to that of FRPE (Figure 3).
Effect of FRPE and FRME on the histopathology of 
liver
The protective effects of FRPE and FRME were con-
firmed by histopathological examination of the liver 
Table 1. Effect of FRPE and FRME on serum proteins, urea, creatinine and total bilirubin.
Groups Total protein (g/dL) Serum albumin (g/dL) Total bilirubin (mg/dL) Creatinine (mg/dL) Urea (mg/dL)
Control 5.9 ± 0.16d 3.4 ± 0.05d 0.2a ± 0.02 0.5a ± 0.01 45.1d ± 0.37
FRPE 5.20 ± 0.15b 2.50 ± 0.08b 0.8b ± 0.03 0.6a ± 0.01 40.9b ± 0.63
FRME 5.47 ± 0.11c 2.86 ± 0.04c 0.3a ± 0.01 0.5a ± 0.02 42.8c ± 0.94
LIV 5.25 ± 0.22bc 2.53 ± 0.07b 0.7b ± 0.03 0.5a ± 0.03 40.9b ± 0.86
CCL
4
4.5 ± 0.06a 2.1 ± 0.04a 2.1c ± 0.05 0.7a ± 0.03 37.9a ± 0.76
*Values are mean ± SD (n = 6).
**FRPE, petroleum ether extract-treated rats; FRME, methanol extract-treated rats; LIV, Liv52-treated rats; CCl
4
, untreated rats.
#Values carrying different superscript letters a, b, c, d in columns differ significantly (p ≤ 0.05).























Figure 1. Effect of FRPE and FRME on serum hepatic enzymes.





































Figure 4. (A) Section of the liver tissue of control rats showing normal hepatocytes and central vein. (C) Section of the liver tissue of rats treated 
with CCl
4
 showing severe necrosis, neutrophil infiltrate and inflammatory changes. (D) Section of the liver tissue of FRPE-pretreated rats showing 
normal hepatocytes necrosis and fatty changes. (B) Section of the liver tissue of FRME-pretreated rats showing normal hepatocytes and central 
vein. (E) Section of the liver tissue of Liv52-pretreated rats showing inflammatory changes and necrosis. NH, normal hepatocytes; CV, central 





































Figure 2. Effect of FRPE and FRME on serum, hepatic, renal TBARS.
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sections. In control animals, liver sections showed 
normal hepatic cells with well-preserved cytoplasm, 
prominent nucleus, nucleolus and central vein 
(Figure 4A) similar observations were also found in 
FRME pretreated rats (Figure 4B). In CCl
4
-treated 
rats the sections showed intense necrosis, steatosis 
and inflammation with neutrophil infiltration of the 
hepatic cytoplasm (Figure 4C). Pretreatment with 
FRPE, and Liv52 showed considerable improvement in 
the hepatocellular architecture over CCl
4
-treated rats, 
as reflected from a significant reduction in hepatic 
necrosis (Figure 4D & 4E, respectively), however, 
fatty cellular changes were seen in both the groups. 
Vacuolated cells were seen in FRPE rats, and on the 
other hand, severe inflammation around the portal 
triad was seen in Liv52 pretreated rats.
Discussion
Carbon tetrachloride is one of the most commonly 
used hepatotoxins in the experimental study of liver 
diseases. The hepatotoxic effects of CCl
4
 are largely 
due to its active metabolite, trichloromethyl radical 
(Johnston & Kroening, 1998; Srivastava et al., 1990). It 
is well established that CCl
4
 administration causes a 
significant decrease in serum urea, total protein and 
albumin levels (Ogeturk et al., 2004) and in the present 
investigation a significant decrease in the levels of 
total protein, albumin and albumin/globulin ratio was 
observed. However, pretreatment with the extracts of F. 
racemosa significantly restored the serum protein lev-
els nearer to control levels. The decrease in serum pro-
tein content might be ascribed to liver damage caused 
by CCl
4
 as reports indicate that liver damage causes 
decreased amino acid uptake or hepatic protein syn-
thesis (El-Shenawy & Abdel-Nabi, 2006). As reported 
in other studies (Ogeturk et al., 2004) CCl
4
 administra-
tion decreased serum urea levels considerably in com-
parison with control rats which marginally increased 
towards normalization in groups pretreated with F. 
racemosa extracts. However, some investigators have 
reported an increase in serum urea concentrations in 
CCl
4
-treated rats and attributed these changes in urea 
levels to the reduction in the glomerular filtration rate 
as a result of CCl
4
 intoxication, since the serum concen-
tration of these two parameters depends largely on the 
glomerular filtration (Moawad, 2007). Such an increase 
in urea levels may also depend on the CCl
4
 intoxication 
levels. The protective effect exhibited by Liv52 was sim-
ilar to that of FRPE. FRME exhibited maximum protec-
tion and restored serum protein levels effectively. We 
observed a marginal increase in the serum creatinine 
levels of CCl
4
-treated rats compared to control rats but 
the difference did not reach statistical significance. The 
effect of CCl
4
 on serum creatinine levels is controver-
sial. Some investigators have reported a decrease in 
serum creatinine in CCl
4
 toxicity, while others have 
found no significant changes (Ozdogan et al., 2002). In 
our study, creatinine values in CCl
4
 administered rats 
did not differ from control values.
Hepatotoxic compounds such as CCl
4
 are known to 
cause elevation in serum transaminases. As expected, in 
the present study CCl
4
 induced severe hepatic damage 
as represented by markedly elevated levels of ALT, AST, 
ALP and total bilirubin. The significant reductions in the 
activities of serum transaminases (AST and ALT), alka-
line phosphatase and total bilirubin content brought 
about by the pretreatment with FRME could be due to 
the presence of bergenin, an isocoumarin (Veerapur 
et al., 2007) reported to exhibit significant hepatopro-
tective activity (Lim et al., 2000). Liv 52 is reported to 
exhibit significant hepatoprotective effect and improve 
liver functionality in CCl
4




 induces hepatotoxicity by metabolic activation; 
therefore it selectively causes toxicity in liver cells main-
taining semi-normal metabolic function. CCl
4
 is meta-
bolically activated by the cytochrome P
450
-dependent 
mixed oxidase in the endoplasmic reticulum to form 
a trichloromethyl free radical (·CCl
3
) which combines 
with cellular lipids and proteins in the presence of 
oxygen to induce lipid peroxidation (Recknagel et al., 
1977; De Groot & Noll, 1986). Both FRPE and FRME 
decreased lipid peroxidation to near normal levels. 
Similar observations are reported with respect to Liv52 
which significantly decreased malonaldialdehyde 
content in CCl
4
 intoxicated rats (Pandey et al., 1994). 
Reports indicate that some natural extracts contain-
ing antioxidants protect against the CCl
4
-induced lipid 
peroxidation and impairment in GSH status (Ko et al., 
1995). The reduction in oxidative stress by the extracts 
of F. racemosa could be attributed to the presence of 
tannins, kaempferol, rutin, bergapten, psoralenes, 
flavonoids, ficusin, coumarin and phenolic glycosides 
(Baruah & Gohain, 1992), bergenin and racemosic 
acid (Li et al., 2004) that are reported to act as strong 
antioxidant and anti-inflammatory agents (Khan & 
Sultana, 2005).
In states of oxidative stress, GSH is converted to 
glutathione disulfide and depleted, leading to lipid 
 peroxidation. Therefore, the role of GSH as a reasonable 
marker for the evaluation of oxidative stress is important 
(Recknagel et al., 1977). FRPE, FRME and Liv52 inhibited 
lipid peroxidation and elevated depleted serum, hepatic 
and renal GSH levels towards normalization.
Histopathological studies showed that CCl
4
 caused 
severe necrosis, neutrophil infiltration and hydropic 
degeneration of the liver tissue. Pretreatment with 
extracts exhibited considerable hepatic protection, 
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which confirmed the results of biochemical studies. All 
the effects of the extracts were comparable with those 
of Liv52, a proven hepatoprotective tonic (Chauhan 
et al., 1994; Kothari et al., 1990; Kataria & Singh, 1997; 
Gopumadhavan et al., 1993; Dhawan & Goel, 1994). It 
is noteworthy to state that FRME exhibited maximum 
hepatoprotective effect as reflected by both biochemi-
cal parameters and histopathology of liver sections. The 
effect was far superior to Liv52 which can be attributed 
to the presence of bergenin, a known hepatoprotec-
tive agent and racemosic acid, a strong antioxidant (Li 
et al., 2004; Lim et al., 2000). The hepatoprotective effect 
of FRPE may be attributed to the presence of lupeol 
acetate, a triterpenoid (Rahman et al., 1994). The results 
of our study indicate that simultaneous treatment with 





The present study is suggestive of the fact that CCl
4
 causes 
hepatic damage in rats through enhanced lipid peroxida-
tion and alterations in antioxidant defenses. The results 
demonstrate that F. racemosa has potent hepatoprotec-
tive action against CCl
4
-induced hepatic damage in rats 
and this effect may be mediated through its antioxidative 
action. These observations justify the use of F. racemosa 
as traditional medicine in the treatment of jaundice. 
Further investigations are underway to isolate the phyto-
constituents responsible for its hepatoprotective effect.
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